Status:

COMPLETED

AcAdeMiC: Acting With Acceptance, Mindfulness and Compassion to Overcome Test/Exam Anxiety

Lead Sponsor:

University of Coimbra

Collaborating Sponsors:

Fundação para a Ciência e a Tecnologia

Conditions:

Adolescents

Test Anxiety

Eligibility:

All Genders

13-18 years

Phase:

NA

Brief Summary

Test Anxiety is a highly prevalent and impairing condition in adolescents (i.e., 9th to 12th grade students), significantly impacting on their mental health and well-being. Among Portuguese university...

Detailed Description

All ethical and deontological requirements are guarenteed in this study. A sample of adolescent students (from 9th to 12th grade) is being online-recruited, through social media and contacts with Exe...

Eligibility Criteria

Inclusion

  • provision of written informed consent by participants and their legal guardians;
  • presence of high levels of test anxiety, confirmed through self-report assessment and clinical interview;
  • educational level from 9th to 12th grade;
  • absence of Neurodevelopmental Disorders, except Specific Learning Disorders of mild severity;
  • absence of any degree of cognitive decline or impairment;
  • absence of any severe Depressive Disorder;
  • absence of any other severe psychiatric condition (e.g., Obsessive-Compulsive Disorder, Bipolar Disorder, Psychotic Disorders);
  • not being under treatment for a psychiatric condition.

Exclusion

  • no provision of written informed consent by participants and their legal guardians;
  • absence of high levels of test anxiety, confirmed through self-report assessment;
  • educational level below 9th and above 12th grade;
  • presence of Neurodevelopmental Disorders, except Specific Learning Disorders of mild severity;
  • presence of any degree of cognitive decline or impairment;
  • presence of any severe Depressive Disorder;
  • presence of any other severe psychiatric condition (e.g., Obsessive-Compulsive Disorder, Bipolar Disorder, Psychotic Disorders);
  • being under treatment for a psychiatric condition.

Key Trial Info

Start Date :

March 15 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 31 2022

Estimated Enrollment :

64 Patients enrolled

Trial Details

Trial ID

NCT04861116

Start Date

March 15 2021

End Date

July 31 2022

Last Update

December 2 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Coimbra

Coimbra, Portugal, 3000-115